The National Agency for Food and Drug Administration and Control (NAFDAC) has raised concerns over the alarming discoveries made at three major open drug markets in Nigeria. The agency’s Director-General, Professor Mojisola Adeyeye, revealed that a large cache of fake, banned, and unregistered drugs was seized during enforcement operations at the Idumota Open Drug Market in Lagos, Ariaria Drug Market in Aba, and the Bridge Market in Onitsha. She warned that the circulation of these counterfeit medications poses a grave threat to public health, potentially endangering millions of lives.
Speaking at a news conference in Lagos, Adeyeye disclosed that approximately 100 truckloads of illegal pharmaceuticals, including dangerous substances such as tramadol and codeine syrups, were evacuated from the markets. These drugs, many of which are stored in unsanitary conditions, account for a significant portion of the medications distributed across the country. She noted that if patients with conditions such as Diabetes or Hypertension consume these falsified drugs, they risk severe health complications or even death. The agency has already destroyed 27 truckloads of confiscated products from Idumota and remains committed to eliminating such harmful substances from circulation.
Illegal drug markets persist despite past crackdowns.
This discovery highlights a long-standing problem in Nigeria’s pharmaceutical sector, where unregulated drug markets continue to thrive despite past crackdowns. These markets serve as distribution hubs for over 80 percent of medications in circulation, making them a major source of both genuine and counterfeit drugs. The lack of strict regulatory oversight has allowed traders to stockpile unverified pharmaceuticals, many of which contain harmful substances or are stored under improper conditions. This situation has contributed to the persistence of substandard drugs, which not only put consumers at risk but also undermine the credibility of the country’s healthcare system.
In addition to the immediate health implications, the widespread availability of fake drugs also has economic consequences. Pharmaceutical companies that adhere to regulatory standards face unfair competition from sellers of substandard products, many of whom offer cheaper alternatives that attract unsuspecting buyers. This unfair Market Environment discourages Investment in the sector and affects the livelihoods of professionals who depend on the legal Trade of quality medicines. If left unchecked, the circulation of falsified drugs could weaken the local Pharmaceutical Industry and increase Nigeria’s reliance on imported medications.
Confiscation alone won’t stop counterfeit drugs.
Furthermore, NAFDAC’s recent enforcement actions, though significant, may not be enough to permanently curb the activities of illegal drug traders. While confiscating and destroying counterfeit drugs is a necessary step, more must be done to prevent their re-entry into the market. Strengthening border controls, tightening licensing requirements, and increasing penalties for offenders are some of the measures that could help address the problem. The agency has emphasised the need for open drug markets to be relocated to coordinated wholesale centres, where stricter regulations can be enforced, but ensuring compliance remains a challenge.
Public awareness is also a crucial aspect of tackling this issue. Many Nigerians unknowingly purchase falsified medications, assuming they are genuine. Educating consumers on how to identify registered and quality-assured drugs could reduce demand for counterfeit products. At the same time, healthcare professionals and pharmacists must be more vigilant in sourcing their supplies to prevent the distribution of dangerous medications. By promoting a Culture of accountability, the country can reduce the risks associated with unregulated drug markets.
Related Article: Combating fake drugs in Nigeria’s healthcare
While NAFDAC’s efforts signal progress, sustained enforcement and regulatory reforms will be necessary to protect public health. Without a long-term plan, these illegal markets could resurface in different locations, continuing to endanger lives and undermining trust in the healthcare system. To truly combat the problem, authorities must adopt a comprehensive approach that tackles the root causes of counterfeit drug distribution, such as weak supply chain oversight and limited access to affordable medications. Strengthening surveillance, increasing public awareness, and ensuring that safe, effective, and reasonably priced medicines are accessible to all Nigerians will be key to achieving lasting change.